血液透析滤过处理CAR-T治疗后IL-6受体抑制剂治疗无效的3~4级细胞因子释放综合征3例

OBJECTIVE: To investigate the efficacy and safety of hemodiafiltration (HDF) in treating CAR-T related grade 3–4 cytokine release syndrome after ineffective treatment with IL-6 receptor inhibitors. METHODS: Between July 2015 and July 2021, retrospective analysis of hemodiafiltration for the treatmen...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2022
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800215/
https://www.ncbi.nlm.nih.gov/pubmed/35968593
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.06.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800215/
https://www.ncbi.nlm.nih.gov/pubmed/35968593
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.06.009

Ejemplares similares